Literature DB >> 8551762

Decision making for the surgical management of aortic coarctation associated with ventricular septal defect.

R M Brouwer1, A H Cromme-Dijkhuis, M E Erasmus, C Contant, A J Bogers, N J Elzenga, T Ebels, A Eijgelaar.   

Abstract

Coarctation of the aorta and associated ventricular septal defect may be repaired simultaneously or by initial coarctation repair with or without banding of the pulmonary artery. The question is whether specific preoperative criteria can enable the surgeon to choose the optimal surgical management. Between 1980 and 1993, 80 infants younger than 3 months with coarctation and ventricular septal defect were treated surgically. In 64 infants (multistage group), simple coarctation repair was performed through a posterolateral approach, with concomitant banding of the pulmonary artery in 10 infants. Twenty ventricular septal defects were closed as a secondary procedure and four were closed as a tertiary procedure. Sixteen infants (single-stage group) underwent one-stage repair through an anterior midline approach. The total in-hospital mortality rate was 7.5%. Freedom from recoarctation after 5 years was 91.3% in the multistage group versus 60.0% in the single-stage group (p = 0.018). Freedom from secondary ventricular septal defect treatment in the multistage group after 5 years was 40.7%, versus 100% in the single-stage group (p = 0.016). Thirty-seven ventricular septal defects (47.8%) closed spontaneously. In particular, the preoperative left-to-right shunt and extension of the perimembranous VSD into the inlet or outlet were risk factors for the need for eventual surgical ventricular septal defect closure after initial coarctation repair. On the basis of these two risk factors, the probability of the need for eventual surgical treatment of ventricular septal defect after initial coarctation repair can be calculated. This policy offers a well-considered choice between single-stage and multistage repair, weighing the risk of secondary ventricular septal defect treatment versus the risk of recoarctation. Finally, the number of surgical procedures per infant will be as low as possible.

Entities:  

Mesh:

Year:  1996        PMID: 8551762     DOI: 10.1016/S0022-5223(96)70413-0

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Management of an associated ventricular septal defect at the time of coarctation repair.

Authors:  Mark D Plunkett; Brian A Harvey; Lazaros K Kochilas; Jeremiah S Menk; James D St Louis
Journal:  Ann Thorac Surg       Date:  2014-08-19       Impact factor: 4.330

2.  Echocardiographic findings for improved prenatal diagnosis of aortic coarctation with ventricular septal defect.

Authors:  Yunyu Chen; Huixian Li; Danping Huang; Jinrong Liu; Rui Zhang; Wenjia Lei; Yongen Liang; Yanqin Cui; Yuanyuan Gu; Weihui Shentu; Hongying Wang
Journal:  Int J Cardiovasc Imaging       Date:  2021-12-21       Impact factor: 2.357

3.  The limitation of staged repair in the surgical management of congenital complex heart anomalies with aortic arch obstruction.

Authors:  Ryo Aeba; Toshiyuki Katogi; Kenichi Hashizume; Yoshimi Iino; Kiyoshi Koizumi; Kentaro Hotoda; Shinya Inoue; Hideki Matayoshi; Akihiro Yoshitake; Ryohei Yozu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-07

4.  Continuous cerebral and myocardial perfusion during one-stage repair for aortic coarctation with ventricular septal defect.

Authors:  Huiwen Chen; Haifa Hong; Zhongqun Zhu; Jinfen Liu
Journal:  Pediatr Cardiol       Date:  2012-11-07       Impact factor: 1.655

5.  Prognostic Model to Predict Postoperative Adverse Events in Pediatric Patients With Aortic Coarctation.

Authors:  Yan Gu; Qianqian Li; Rui Lin; Wenxi Jiang; Xue Wang; Gengxu Zhou; Junwu Su; Xiangming Fan; Pei Gao; Mei Jin; Yuan Wang; Jie Du
Journal:  Front Cardiovasc Med       Date:  2021-05-21

6.  Diagnosis and Surgical Repair for Coarctation of the Aorta With Intracardiac Defects: A Single Center Experience Based on 93 Infants.

Authors:  Yuhao Wu; Jiashan Li; Chun Wu; Jin Zhu; Ling He; Chuan Feng; Yiting Yang; Xin Jin
Journal:  Front Pediatr       Date:  2020-03-03       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.